CITIUS PHARMACEUTICALS INC(NASDAQ:CTXR) stock Analyst Ratings

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 80% to CTXR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.78. This target is 270.52% above the current price.

CTXR was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CTXR.

In the previous month the buy percentage consensus was at a similar level.

CTXR was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

1.56

4.04

4.08

5.78

9.45

158.97%

161.54%

270.52%

505.77%

Up and Down Grades

Date	Firm	Action	Rating
2025-06-30	D. Boral Capital	Maintains	Buy -> Buy
2025-06-10	D. Boral Capital	Maintains	Buy -> Buy
2025-06-09	D. Boral Capital	Maintains	Buy -> Buy
2025-05-23	Maxim Group	Downgrade	Buy -> Hold
2025-05-15	D. Boral Capital	Maintains	Buy -> Buy
2025-02-18	D. Boral Capital	Maintains	Buy -> Buy
2025-01-07	D. Boral Capital	Maintains	Buy -> Buy
2024-12-30	D. Boral Capital	Upgrade	Hold -> Buy
2024-11-22	D. Boral Capital	Downgrade	Buy -> Hold
2024-11-12	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-11-11	D. Boral Capital	Maintains	Buy -> Buy
2024-08-19	EF Hutton	Maintains	Buy -> Buy
2024-08-08	EF Hutton	Maintains	Buy -> Buy
2024-08-05	EF Hutton	Maintains	Buy -> Buy
2024-07-15	EF Hutton	Initiate	Buy
2024-05-31	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-02-14	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-08-10	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-08-01	HC Wainwright & Co.	Maintains	Buy -> Buy
2023-05-30	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-04-03	HC Wainwright & Co.	Reiterate	Buy
2023-03-29	HC Wainwright & Co.	Reiterate	Buy
2022-01-18	HC Wainwright & Co.	Maintains	Buy
2021-11-30	Maxim Group	Initiate	Buy

CITIUS PHARMACEUTICALS INC (CTXR) Stock Analyst Ratings